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The global incidence of diabetes is set to rise dramati-
cally from an estimated 382 million people in 2013 to 592 
million by 2030. Diabetic retinopathy (DR) is one of the most 
frequent complications of diabetes and the leading cause of 
blindness among working-age individuals [1]. In the past, 
DR was recognized solely as a vascular disease; however, 
a large number of cellular and molecular preclinical studies 
and retinal function tests in patients with DR have shown 
that retinal neurodegeneration (diabetic retinal neuropathy) 
is an early event in the pathogenesis of DR that predates and 
participates in diabetic retinal vasculopathy [2,3].
Increasing evidence shows that in the retina apoptosis 
of neural cells and reactive gliosis are basic pathological 
features of early DR [4]. Among all neuronal cell types in the 
retina, retinal ganglion cells (RGCs) are highly susceptible 
to hyperglycemia-mediated apoptosis, but photoreceptors are 
also one of the primary cell types affected in diabetic retinal 
neuropathy. Increased levels of photoreceptor apoptosis 
have been found in histological sections of animal models 
of diabetes [5], and thinning of the photoreceptor layer was 
noted on optical coherence tomography (OCT) scanning in 
patients with diabetes [6]. Importantly, injury in RCGs and 
photoreceptors, which was reflected by the results of elec-
troretinogram (ERG) examination, was not associated with 
DR-specific vascular injury [7].
At the molecular level, the mitochondria-dependent 
(intrinsic) pathway has been demonstrated to be closely 
related to diabetes-induced retinal cell apoptosis [8]. This 
pathway, activated by oxidative and endoplasmic reticulum 
stress, is controlled through the balance in the expression 
of the Bcl-2 family proteins, including the antiapoptotic 
members Bcl-2 and Bcl-xL and the proapoptotic protein 
Bax, and determines the survival or death of the retinal 
cells following diabetic stimuli [9]. Activation of the death 
receptor-mediated (extrinsic) apoptotic pathway is also 
involved in retinal apoptosis during DR. We have recently 
reported that several proapoptotic molecules of both classical 
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Purpose: Many cellular and molecular studies in experimental animals and early retinal function tests in patients with 
diabetic retinopathy (DR) have shown that retinal neurodegeneration is an early event in the pathogenesis of the dis-
ease. Somatostatin (SST) is one of the most important neuroprotective factors synthesized by the retina: SST levels are 
decreased in parallel to retinal neurodegeneration in early stages of DR. In this study, we characterized the induction of 
apoptosis (programmed cell death) in a 661W photoreceptor-like cell line cultured under high glucose (HG) conditions 
and the effect of SST.
Methods: A 661W photoreceptor-like cell line and retinal explants from 10-week-old male C57BL/6 mice were cultured 
under HG conditions and treated with SST.
Results: Hyperglycemia significantly reduced the cellular viability by increasing the percentage of apoptotic cells, and 
this effect was ameliorated by SST (p˂0.05). Activation of caspase-8 by hyperglycemia was found in the 661W cells and 
retinal explants and decreased in the presence of SST (p˂0.05). Moreover, we detected activation of calpain-2 associated 
with hyperglycemia-induced cell death, as well as increased protein tyrosine phosphatase 1B (PTP1B) protein levels; 
both had a pattern of cleavage that was absent in the presence of SST (p˂0.05). Treatment of the 661W cells and retinal 
explants with SST for 24 h increased the phosphorylation of type 1 insulin-like growth factor receptor (IGF-IR; tyrosine 
1165/1166) and protein kinase B (Akt; serine 473), suggesting this survival signaling is activated in the neuroretina by 
SST (p˂0.05).
Conclusions: This study has provided new mechanistic insights first into the involvement of calpain-2 and PTP1B in the 
loss of cell survival and increased caspase-8-dependent apoptosis induced by hyperglycemia in photoreceptor cells and 
second, on the protective effect of SST against apoptosis by the enhancement of IGF-IR-mediated Akt phosphorylation.
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pathways (FasL, active caspase-8, truncated Bid, Bim, and 
active caspase-3) are significantly increased in the neuro-
retina of diabetic patients with diagnosed DR [10]. Based on 
all these and other studies, it is reasonable to hypothesize that 
the identification of novel molecular regulatory mechanisms 
of apoptosis in the neural cells of the retina will be useful for 
the development of therapeutic strategies against DR based 
on neuroprotection.
Somatostatin (SST) is one of the most important neuro-
protective factors synthesized by the retina, and the RPE is 
the main source of SST in the human eye [11]. The human 
retina produces significant amounts of SST, as deduced by the 
strikingly high levels reported within the vitreous fluid [12]. 
Among the five types of SST receptors, SST1 and SST2 are 
the most widely expressed in the retina [13,14]. The produc-
tion of SST and SST1 receptor simultaneously suggests a 
relevant autocrine action in the retina. SST1 receptor immu-
noreactivity has been reported in SST-expressing amacrine 
cells of the rat [15]. Moreover, the SST1 receptor has been 
shown to modulate the release of SST in the rat retina and 
acts as SST’s autoreceptor [16]. In human ocular tissue, SST1 
and SST2 receptor immunostaining was reported in the outer 
and inner segments of rods and cones [13], whereas in the 
rat retina the two isoforms of the SST2 receptor, SST2A 
and SST2B, have been localized in the outer retina to cone 
photoreceptors [17] and to rod and cone photoreceptors [18], 
respectively. Importantly, during early DR, lower SST expres-
sion parallels retinal neurodegeneration [11]. Moreover, the 
lower production of SST in the retina is associated with a 
dramatic decrease in SST levels in the vitreous in diabetic 
patients with proliferative DR [12,19] and with diabetic 
macular edema [20].
We recently analyzed the effect of topical treatment with 
SST in the apoptotic cascade of an experimental model of DR 
in rats [21]. In this previous study, we found a significant rate 
of apoptosis in the retinas from streptozotocin (STZ)-induced 
diabetic rats in comparison with non-diabetic control rats, 
which correlated with a misbalance between the apoptotic 
and survival signaling pathways. This balance was favored 
toward survival by treatment with SST in parallel with an 
improvement of the visual function. On that basis, the aim of 
the present work is to provide in a cellular-specific context 
using 661W photoreceptor-like cells new molecular insights 
into the effect of SST in the altered balance between apop-
tosis and cell survival under diabetic conditions.
METHODS
Reagents and drugs: Fetal bovine serum (FBS) and culture 
media were obtained from Invitrogen (Grand Island, NY). 
Bovine serum albumin (BSA) was purchased from Sigma-
Aldrich (St. Louis, MO). Bradford reagent, acrylamide, 
immunoblot polyvinylidene fluoride (PVDF) membranes, and 
chemoluminescent horseradish peroxidase (HRP) substrate 
were purchased from Bio-Rad (Madrid, Spain). Somatostatin 
was obtained from BCN peptides S.A. (Barcelona, Spain).
Retinal explants: Ex vivo assays were performed in retinas 
from 10-week-old male C57BL/6 mice purchased from 
Charles River Laboratories (Barcelona, Spain). Mice were 
maintained in light/dark (12 h:12 h light-dark) and tempera-
ture- (22 °C), and humidity-controlled rooms, and fed ad 
libitum with free access to water. All animal experimenta-
tion was conducted in accordance with the regulations of 
the Association for Research in Vision and Ophthalmology 
(ARVO) and approved by the Animal Care and Use Commit-
tees of Spanish National Research Council (CSIC). Animals 
were killed by cervical dislocation, eyes were enucleated, 
and then the lens, anterior segment, vitreous body, RPE, 
and sclera were removed. For experiments, the retinas were 
cultured in R16 medium (provided by PA Ekstrom, Lund 
University, Sweden) containing 19 mM glucose (basal condi-
tion; B) or in the same medium supplemented with glucose 
up to a concentration of 55 mM (high glucose, HG) in the 
absence or presence of SST (10−6 M) during 24–48 h.
Cell culture: The 661W cell line, derived from immortal-
ized cone photoreceptors (provided by Muayyad Al-Ubaidi, 
University of Oklahoma), was maintained in Dulbecco’s 
modified Eagle’s medium (DMEM, Invitrogen, ThermoFisher 
Scientific, Waltham, MA) containing 4.5 g/l (24.5 mM) 
glucose and supplemented with 10% (vol/vol) heat-inactivated 
FBS as described [22]. For mouse cell line authentication, 
genomic DNA was isolated from the 661W cells and analyzed 
with PCR as described [23]. PCR conditions were as follows: 
10 min 95 ºC; 45 s 94 ºC, 2 min 59 ºC, 1 min 72 ºC (30 cycles) 
and 10 min 60 ºC. Amplified products were analyzed in a 2% 
agarose gel. The following primer sequences were used for 
amplification of the mouse short tandem repeat (STR) loci 
named 6-7 and 15-3: forward (6–7), 5′-AGT CCA CCC AGT 
GCA TTC TC-3′; reverse (6–7), 5′-CAT GTG GCT GGT ATG 
CTG TT-3′; forward (15–3), 5′-TCT GGG CGT GTC TGT 
CAT AA-3′; and reverse (15–3), 5′-TTC TCA GGG AGG 
AGT GTG CT-3′. Appropriate positive (mouse) and negative 
(human) controls were run and confirmed for each sample 
submitted. The STR analyses are presented in Appendix 1. 
In this study we have used a cell line from mouse origin and 
we did not analyze different STR locus as in human cell line 
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authentication. For mouse (661W) cell line analysis we just 
amplify two mouse specific STR named 6-7 and 15-3. For 
the experiments, confluent cells were maintained in 24.5 mM 
glucose (basal condition) or cultured in 55 mM glucose (HG) 
during 24–48 h in the presence or absence of SST (10−6 M).
Western blot: For western blot analysis, the proteins were 
resolved using denaturing sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis (SDS–PAGE) and transferred 
to PVDF membranes (Bio-Rad, Madrid, Spain). Levels of 
phosphorylated proteins (type 1 insulin-like growth factor 
receptor [pIGF-IR] and protein kinase B [pAkt]) were 
normalized by the levels of their corresponding total (IGF-IR 
and Akt) proteins that were used as loading controls. Levels 
of protein tyrosine phosphatase 1B (PTP1B), caspase-8, 
and calpain-2 were normalized with β-actin. Anti-IGF-IR 
(sc-713), anti-phospho-Akt1/2/3 (Ser473; sc-7985-R), anti-
Akt1/2/3 (sc-8312), and anti-caspase-8 (sc-7890) antibodies 
were purchased from Santa Cruz Biotechnology (Palo Alto, 
CA). Anti-PTP1B (05–1087, recognizes cleavaged PTP1B) 
antibody was purchased from Merk-Millipore (Merck KGaA, 
Darmstadt, Germany). Anti-calpain-2 (C3989) and anti-β-
actin (A-2547) antibodies were from Sigma-Aldrich (Madrid, 
Spain). Anti-phospho-IGF-IRβ (Tyr1135/1136; #3024) was 
from Cell Signaling Technology (Danvers, MA).
Analysis of cellular viability: Quantification of cellular 
viability was performed using crystal violet staining. Cells 
were seeded in six-well tissue culture plates and allowed 
to stabilize overnight in a 5% CO2 incubator at 37 °C. The 
cells were then cultured in 24.5 mM (basal) or 55 mM (HG) 
glucose-containing medium in the absence or presence of 
SST (10−6 M) for 24–48 h, and cellular viability was measured 
with crystal violet staining as described [24].
Flow cytometry: After apoptosis was induced, adherent and 
non-adherent cells were collected by centrifugation, washed 
with PBS (1X; 136 mM NaCl, 2,67 mM KCl, 10 mM NaPO4, 
1,76 mM KPO4, pH 7), and fixed with cold ethanol (70% 
vol/vol). The cells were then washed, resuspended in PBS, 
and incubated with RNase (25 µg/106 cells) for 30 min at 
37 °C. After 0.05% propidium iodide was added, the cells 
were analyzed with flow cytometry on a FACSCalibur using 
CellQuest software (BD Biosciences, San Jose, CA).
Caspase-8 activity assay: Caspase-8 activity was measured in 
retinal explants with a fluorometric method. After treatment, 
the retinal explants were lysed at 4 °C in 5 mM Tris/HCl 
pH 8, 20 mM EDTA, and 0.5% Triton X-100. Lysates were 
clarified by centrifugation at 13,000 ×g for 10 min. Caspase 
8-activity was measured with the ApoAlert caspase-8 
fluorescent assay kit (Clontech, Ref. K2028) accordingly 
with the manufacturer’s instructions using IETD-AFC as a 
fluorometric substrate. Protein concentration of cell lysates 
was determined with the Bradford method, and results are 
expressed as caspase-8 activity per µg of total protein.
Statistics: Densitometry of the western blots was performed 
using the Image J program. Values in all graphs represented 
the mean ± standard error of the mean (SEM). Statistical 
tests were performed using SPSS 21.0 for Windows (SPSS 
Inc. IBM, Armonk, NY) with data corresponding to three 
independent experiments performed in duplicate and/or n 
= 5 independent retinas per condition. Data were analyzed 
with one-way ANOVA followed by the Bonferroni t test or by 
the paired t test when comparisons were among two groups. 
Differences were considered statistically significant at a p 
value of less than 0.05.
RESULTS
SST increased survival and decreased hyperglycemia-
induced apoptosis and caspase-8 activation in 661W photo-
receptors and retinal explants: It is known that during DR, 
hyperglycemia is present in neuroretinal tissue and plays 
a key role in neurodegeneration [25]. We first character-
ized the induction of programmed cell death in the 661W 
photoreceptor-like cell line cultured under HG for 24 and 48 
h compared with cells cultured under basal conditions (B). As 
shown in Figure 1A, hyperglycemia statistically significantly 
reduced the cellular viability of the 661W cells as reflected 
by quantification of the crystal violet staining (p<0.05 HG 
versus B); this effect was reversed in cells cultured in HG 
plus SST (10−6 M; p<0.05 versus HG).
Next, we measured the percentage of hypodiploid (apop-
totic) cells in these experimental conditions. As depicted in 
Figure 1B, the percentage of apoptotic cells significantly 
increased in the 661W cells cultured in HG-supplemented 
medium for 24 and 48 h. However, in cells cultured with 
HG plus SST, a statistically significant decrease was found 
in the percentage of apoptotic cells (p<0.05 versus HG). 
These results are in agreement with our recent in vivo study 
in which topical administration of SST decreased apoptotic 
(terminal deoxynucleotidyl transferase dUTP nick end 
labeling [TUNEL] positive) cells in the retina and improved 
visual function in diabetic rats [21].
The molecular analysis of the retina in the SST-treated 
diabetic rats revealed that hyperglycemia positively modu-
lated the death receptor (extrinsic) apoptotic pathway [21]. To 
examine the effect of SST on this apoptotic pathway in a cell 
autonomous-specific manner, we treated the 661W photore-
ceptor cells with HG-supplemented medium in the absence 
or presence of SST for 24 h and analyzed the cleavage of 
caspase-8 proform (65 kDa) in its 35-kDa active fragment 
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Figure 1. SST increases survival and decreases apoptosis and caspase-8 activation induced by hyperglycemia in 661W photoreceptors and 
retinal explants. The 661W cells were cultured under basal conditions (B) or in medium supplemented with 55 mM glucose (HG) during 
24 or 48 h in the absence or presence of 10−6 M somatostatin (SST). A: Analysis of cellular survival measured with crystal violet staining. 
B: Analysis of the percentage of apoptotic (hypodiploid) cells with iodine propidium staining with flow cytometry. Results are means ± 
standard error of the mean (SEM; n = 5 independent experiments performed in triplicate). C: 661W cells were cultured under basal condi-
tions (B) or with medium supplemented with 55 mM glucose (HG) during 24 h in the absence or presence of 10−6 M SST. The activation of 
caspase-8 was expressed by the ratio of the 35-kDa active fragment/65-kDa proform that was analyzed with western blot. β-actin was used 
as a loading control. A representative experiment out of three is shown. The graph corresponds to the quantification and statistical analysis 
of data corresponding to three independent experiments performed in duplicate. D: Retinal explants were prepared from the C57BL/6 mice 
and treated with basal medium (B) or medium supplemented with 55 mM glucose (HG) during 24 or 48 h in the presence or absence of SST 
(10−6 M). Caspase-8 enzymatic activity was analyzed with the fluorometric method. Results are means ± SEM (n=5 independent retinas per 
condition); *p<0.05 versus basal or †p<0.05 versus HG condition at each time.
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as a hallmark of activation. As shown in Figure 1C, in the 
661W cells treated for 24 h with HG-supplemented medium 
the activation of caspase-8, monitored by the increased ratio 
of the 35-kDa active fragment/65-kDa proform, was detected. 
Treatment with SST prevented the activation of caspase-8 as 
assessed by the reduced levels of the 35-kDa/65-kDa ratio. To 
evaluate the relevance of the effect of SST on the modulation 
of caspase-8 activity in the whole retina, retinas from the 
C57BL/6 mice were cultured under hyperglycemic conditions 
with or without SST for 24 and 48 h. As the active fragment 
of caspase-8 was not detected with western blot in the retinal 
explants (results not shown), we measured caspase-8 enzy-
matic activity with a fluorometric method. The results shown 
in Figure 1D revealed a statistically significant increase in 
caspase-8 enzymatic activity in the retinal explants cultured 
in the HG-supplemented medium (p<0.05 versus basal) 
that was statistically significantly decreased in the explants 
cultured in HG plus SST (p<0.05 versus HG).
SST reduces calpain-2 activation and PTP1B expression 
and cleavage induced by high glucose and directly acti-
vates IGF-IR/Akt phosphorylation in 661W cells and retinal 
explants: To decipher new molecular mechanisms involved in 
the loss of cellular viability in 661W cells cultured under HG 
and the beneficial effect of SST, we analyzed the activation 
of calpain-2. This experimental approach was based on our 
previous work demonstrating that pharmacological inhibition 
of calpain-2 reduced apoptosis during retinal degeneration 
that occurs under increased Ca2+ flux [26]. As demonstrated 
by Saido et al. [27], calpain-2 activation can be measured by 
the autolysis of the 80-kDa catalytic subunit (proform) into 
the 58-kDa fragment [28]. Based on that, we analyzed the 
ratio of the 58-kDa fragment/80-kDa proform of calpain-2 
in 661W cells cultured in HG-supplemented medium for 
24 h. Figure 2A shows that this ratio was increased in the 
661W cells treated with HG-supplemented medium (p<0.05 
versus basal), but the ratio was decreased in cells treated with 
HG plus SST (p<0.05 versus HG), reaching levels that were 
comparable to the basal condition. Interestingly, SST also 
reduced the ratio of the 58-kDa fragment/80-kDa proform of 
calpain-2 under basal conditions, suggesting that 661W cells 
are highly sensitive to the modulation of calpain-2 activity.
It has been shown that in platelets treated with the 
calcium ionophore A23187 the activation of calpain-2 
correlated with the cleavage of PTP1B and the increase in 
its tyrosine phosphatase activity [29]. Likewise, we recently 
reported a similar pattern of cleavage and an increase in 
PTP1B protein expression and enzymatic activity in 661W 
photoreceptors cultured with a mixture of proinflamma-
tory cytokines [30]. These previous results and the present 
findings regarding the activation of calpain-2 in HG-treated 
661W photoreceptors prompted us to analyze the cleavage of 
PTP1B in our experimental settings. As depicted in Figure 
2B, culture of 661W cells under HG for 24 h increased the 
total PTP1B protein levels and induced a pattern of cleavage 
that was not detected in cells cotreated with HG and SST 
(p<0.05 versus basal; p<0.05 versus HG).
Previous results of different groups including ours using 
experimental systems mimicking cellular damage of the 
retina during DR have demonstrated that the IGF-IR/Akt 
pathway mediates survival and protects against the diabetic 
milieu [30-32]. Based on that, we addressed whether SST 
was able to activate this pathway in 661W cells. As shown 
in Figure 2C, treatment with SST for 24 h increased tyrosine 
phosphorylation of the IGF-IR at tyrosines 1165/1166 of the 
catalytic domain, as well as Akt phosphorylation at serine 
473. The phosphorylation of Akt by SST was confirmed 
in retinal explants (Figure 2D) suggesting the physiologic 
relevance of SST in activating the survival signaling in the 
whole retina.
DISCUSSION
Increasing evidence shows that retinal cell apoptosis and 
reactive gliosis are basic pathological features of neurode-
generation during early DR [33]. Consequently, it is impor-
tant to unravel the molecular mechanisms involved in these 
processes to develop neuroprotective treatments aimed at 
avoiding cellular damage in the neural retina at an early stage 
of the disease.
In this study, we used the 661W photoreceptor-derived 
cell line to demonstrate that hyperglycemia triggered caspase-
8-dependent apoptosis. This was manifested by a statistically 
significant increase in the 35-kDa active fragment/65-kDa 
proform ratio, in parallel with an increase in the percentage 
of hypodiploid (apoptotic) cells and with a decrease in the 
total cellular viability. Although this is the first evidence of 
the involvement of caspase-8 in apoptosis of 661W photore-
ceptors under diabetic-like conditions, caspase-8 has been 
previously linked to apoptosis in neural cells cultured under 
HG conditions. For instance, caspase-8 was activated by 
hyperglycemia during apoptotic cell death of neuroblastoma 
PC12 cells [34]. Regarding the impact of caspase-8 activation 
in photoreceptors, a previous study by Chang and coworkers 
showed that light-induced cell death of 661W cells was 
also mediated by caspase-8 [35]. A step further, our results 
demonstrated the activation of caspase-8 in retinal explants 
cultured under HG, suggesting that in addition to photorecep-
tors, other cell types in the neuroretina, likely RGCs, are also 
involved in caspase-8 activation as previously suggested by 
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Figure 2. SST reduces calpain-2 activation and PTP1B expression and cleavage induced by high glucose and directly activates IGF-IR/Akt 
phosphorylation in 661W cells and retinal explants. The 661W cells were cultured under basal conditions (B) or with medium supplemented 
with 55 mM glucose (high glucose, HG) during 24 h in the absence or presence of 10−6 M somatostatin (SST). Levels of the calpain-2 proform 
(80-kDa) and the 58-kDa fragment (A) and the levels of protein tyrosine phosphatase 1B (PTP1B) (B) were analyzed with western blot with 
β-actin as a loading control. The graphs correspond to the quantification and statistical analysis of data obtained in three independent experi-
ments performed in duplicate. *p<0.05 versus basal or †p<0.05 versus HG condition. The 661W cells (C) and the retinal explants (D) were 
treated with SST (10−6 M) for 24 h or left untreated. At the end of the culture time, the phosphorylation levels of type 1 insulin-like growth 
factor receptor (IGF-IR; tyrosine 1165/66) and protein kinase B (Akt; serine 473) were analyzed with western blot. Results were normalized 
with respect to the total IGF-IR or Akt levels. The graphs correspond to the quantification and statistical analysis of data obtained in three 
independent experiments performed in duplicate (C) or five retinas per condition (D). *p<0.05 versus Basal.
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Fuchs and coworkers in a model of tumor necrosis factor-
alpha (TNF-α) stimulation that mimics inflammation during 
DR [36].
Based on the beneficial effect of the topical administra-
tion of SST by improving visual function and reducing neuro-
degeneration, caspase-8 activity and apoptosis in the retina 
of hyperglycemic rats [21], in the present study we assessed 
SST effects in a cellular-specific context in photoreceptors. 
In total agreement with our previous in vivo findings, the 
in vitro and the ex vivo data presented for the 661W cells 
and retinal explants, respectively, demonstrated that SST 
significantly reduced HG-induced caspase-8 activity and the 
percentage of apoptotic (hypodiploid) cells. These findings 
shed light on the mechanisms by which SST could be a useful 
neuroprotective agent for DR.
Various physiologic and molecular abnormalities that are 
consistent with inflammation have been found to be increased 
in the retinas or vitreous humor of diabetic animals and 
patients [37]. Moreover, persistent and unresolved inflam-
mation triggers the activation of proinflammatory signaling 
cascades that ultimately lead to apoptotic cell death [38,39]. 
Among the critical molecules that link the inflammatory 
and cell death processes, PTP1B has been shown to play a 
pivotal role. PTP1B expression is increased in peripheral 
tissues during obesity, and this effect is due to elevated 
proinflammatory signaling [40]. Regarding photoreceptors, 
we have recently reported that treatment of 661W cells with 
proinflammatory cytokines increased PTP1B mRNA and 
protein levels, and this effect was also found in the whole 
retina. Interestingly, cytokines induced a cleavage of PTP1B 
with a similar pattern to that reported in platelets, resulting 
in increased enzymatic activity [29]. Conversely, defi-
ciency in the Ptpn1 gene enhanced the IGF-IR/Akt survival 
signaling in the retina [31] in agreement with another study 
showing that intravitreal administration of a PTP1B inhibitor 
prevented the cleavage of caspase 3 during light stress [41]. 
Altogether, these studies have shown the key role of PTP1B in 
modulating the balance between death and survival processes 
in the retina. In this regard, the results presented here have 
revealed that PTP1B expression and cleavage are markedly 
enhanced by hyperglycemia in 661W photoreceptor-like cells. 
This is the first evidence for hyperglycemia-mediated induc-
tion of PTP1B expression in retinal cells, as occurs in hepa-
tocytes exposed to HG [42], suggesting that increased PTP1B 
expression may partly explain glucose toxicity in diabetes. In 
a previous work, Rajala and coworkers did not found eleva-
tions in PTP1B expression by hyperglycemia in the retinas 
from STZ-treated mice [43]. However, our recent data in the 
retinas from db/db or Irs2−/− diabetic mice models clearly 
showed higher PTP1B expression compared to that of their 
age-matched db+ or Irs2+/+ non-diabetic controls, respectively 
[30,31]. The fact that db/db mice are diabetic and obese and 
display elevations in various inflammatory markers in the 
retina [44] suggests that inflammation might boost the effect 
of hyperglycemia in the enhancement of PTP1B expression 
in the retina.
One potential candidate responsible for the PTP1B 
cleavage by hyperglycemia is calcium-dependent protease 
calpain-2. It has been demonstrated that PTP1B is a substrate 
of calpain-2 and that calpain-2-mediated PTP1B cleavage 
increases its enzymatic activity [45]. Regarding the retina, we 
have previously reported that inhibition of calpain-2 reduced 
apoptosis induced by increased calcium influx and prevented 
retinal degeneration [26]. These studies support our results in 
661W cells cultured in HG-supplemented medium showing 
an increase in the ratio of the 58-kDa fragment/80-kDa 
proform of calpain-2, strongly suggesting that hyperglycemia 
increases its protease activity [27,28]. Interestingly, treatment 
with SST prevented calpain-2 activation and PTP1B cleavage. 
These results reinforce the link between hyperglycemia and 
the activation of calpain-2 and PTP1B in photoreceptors.
PTP1B has emerged as a negative modulator of IR/
IGF-IR tyrosine phosphorylation [46]. However, IGF-IR-
mediated signaling was impaired in the retinas of patients 
with DR [10], and as a result, the balance between apoptosis 
and survival favored cell death. Similarly, in db/db mice that 
recapitulate DR progression, phosphorylation of the IGF-IR 
and its downstream mediator Akt were lower than that of the 
db/+ controls, and importantly, these responses were recov-
ered by topical administration of the glucagon-like peptide 
1 agonist liraglutide [32]. Regarding the effect of SST in 
prosurvival signaling in the retina, our results show for the 
first time that treatment of 661W photoreceptor cells with 
SST markedly induced the tyrosine phosphorylation of the 
IGF-IR at the 1165/1166 residues within the catalytic domain, 
and as a result, it also induced Akt phosphorylation at serine 
473. Therefore, our data strongly suggest that in 661W cells, 
SST might counteract the deleterious effects of hypergly-
cemia by enhancing IGF-IR-mediated Akt phosphorylation. 
Whether SST is able to enhance the local production of IGF-I 
in photoreceptors that, in turn, triggers the activation of the 
IGF-IR in an autocrine manner deserves further investiga-
tion. Moreover, the activation of Akt phosphorylation in 
retinal explants by SST opens up the possibility of the effect 
on prosurvival signaling in other retinal cells.
In conclusion, this study has provided new mechanistic 
insights first into the involvement of calpain-2 and PTP1B in 
the loss of cell survival and increased caspase-8-dependent 
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apoptosis induced by hyperglycemia in 661W photoreceptor 
cells and second, on the protective effect against apoptosis 
and the enhancement of IGF-IR-mediated Akt phosphoryla-
tion by SST. These results support previous findings on the 
beneficial effect of SST in neurodegeneration in the retina and 
pinpoint the therapeutic use of SST against DR progression.
APPENDIX 1. STR ANALYSIS.
To access the table, click or select the words “Appendix 1.”
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